New Research Refines Understanding of Prenatal Immune Factors in Autism

Maternal Immune Activation and Autism Likelihood

Research continues to explore how immune system activity during pregnancy may relate to autism likelihood. A small 2026 exploratory pilot study of 12 twin pairs in Nature found differences in immune signaling proteins (cytokines) in maternal blood and newborn blood spots at birth—though the study design couldn't predict later autism diagnoses. Separately, primate research in Molecular Psychiatry observed altered gene activity in the amygdala—a brain region involved in social-emotional processing—when maternal immune responses were stimulated during pregnancy.

Environmental Factors and Considerations

Beyond infections, environmental factors are also being studied. A 2014 Environmental Health Perspectives study of particulate matter exposure found modest associations with autism likelihood, while a 2023 review in Frontiers in Neuroscience summarized evidence linking maternal metabolic conditions like diabetes to slightly increased autism likelihood, potentially through inflammatory pathways. These factors alone don't determine outcomes, as autism emerges from complex interactions between many genetic and environmental influences.

Ongoing Research Questions While connections between maternal immune activation and autism are being investigated, many questions remain.

Ongoing Research Questions

While connections between maternal immune activation and autism are being investigated, many questions remain. Researchers are examining how timing of immune activity during pregnancy might relate to neurodevelopment, as noted in a 2026 Nature birth cohort study that documented associations rather than mechanisms. Animal studies help explore biological pathways, but human research must account for numerous intersecting factors.